Tracking Kids' health years after brain tumor treatment
NCT ID NCT03975829
Summary
This study follows children and teens who are already taking the medications dabrafenib and/or trametinib for various types of brain tumors. The main goal is to monitor their long-term health, safety, and development while they continue treatment. Researchers will track side effects, growth, heart function, and how well the treatment continues to control their tumors.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Childrens National Hospital
Washington D.C., District of Columbia, 20010, United States
-
Cinn Children Hosp Medical Center
Cincinnati, Ohio, 45229-3039, United States
-
Dana Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
Indiana Uni School of Medicine
Indianapolis, Indiana, 46202-2810, United States
-
Johns Hopkins Hospital
Baltimore, Maryland, 21287, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
Memorial Sloan Kettering Cancer Ctr
New York, New York, 10065, United States
-
Nicklaus Childrens Hospital
Miami, Florida, 33155, United States
-
Novartis Investigative Site
CABA, Buenos Aires, C1428AQK, Argentina
-
Novartis Investigative Site
Darlinghurst, New South Wales, 2010, Australia
-
Novartis Investigative Site
Parkville, Victoria, 3052, Australia
-
Novartis Investigative Site
Brussels, 1200, Belgium
-
Novartis Investigative Site
Barretos, São Paulo, 14784 400, Brazil
-
Novartis Investigative Site
São Paulo, São Paulo, 04829-310, Brazil
-
Novartis Investigative Site
São Paulo, São Paulo, 08270-070, Brazil
-
Novartis Investigative Site
Vancouver, British Columbia, V6H 3V4, Canada
-
Novartis Investigative Site
Toronto, Ontario, M5G 1X8, Canada
-
Novartis Investigative Site
Montreal, Quebec, H3T 1C5, Canada
-
Novartis Investigative Site
Brno, 625 00, Czechia
-
Novartis Investigative Site
Prague, 150 06, Czechia
-
Novartis Investigative Site
Copenhagen, DK-2100, Denmark
-
Novartis Investigative Site
Tampere, 33521, Finland
-
Novartis Investigative Site
Rennes, Brittany Region, 35203, France
-
Novartis Investigative Site
Brest, 29609, France
-
Novartis Investigative Site
Marseille, 13885, France
-
Novartis Investigative Site
Paris, 75231, France
-
Novartis Investigative Site
Rennes, 35033, France
-
Novartis Investigative Site
Vandœuvre-lès-Nancy, 54511, France
-
Novartis Investigative Site
Villejuif, 94800, France
-
Novartis Investigative Site
Cologne, North Rhine-Westphalia, 50937, Germany
-
Novartis Investigative Site
Augsburg, 86179, Germany
-
Novartis Investigative Site
Berlin, 13353, Germany
-
Novartis Investigative Site
Essen, 45147, Germany
-
Novartis Investigative Site
Hamburg, 20246, Germany
-
Novartis Investigative Site
Petah Tikva, 4920235, Israel
-
Novartis Investigative Site
Florence, FI, 50139, Italy
-
Novartis Investigative Site
Genova, GE, 16147, Italy
-
Novartis Investigative Site
Milan, MI, 20133, Italy
-
Novartis Investigative Site
Roma, RM, 00165, Italy
-
Novartis Investigative Site
Torino, TO, 10126, Italy
-
Novartis Investigative Site
Setagaya-ku, Tokyo, 1578535, Japan
-
Novartis Investigative Site
Osaka, 5340021, Japan
-
Novartis Investigative Site
Utrecht, 3584 CS, Netherlands
-
Novartis Investigative Site
Moscow, 117198, Russia
-
Novartis Investigative Site
Madrid, 28009, Spain
-
Novartis Investigative Site
Valencia, 46026, Spain
-
Novartis Investigative Site
Stockholm, 17176, Sweden
-
Novartis Investigative Site
Sutton, Surrey, SM2 5PT, United Kingdom
-
Novartis Investigative Site
Liverpool, L12 2AP, United Kingdom
-
Novartis Investigative Site
London, NW1 2BU, United Kingdom
-
Novartis Investigative Site
London, WC1N 3JH, United Kingdom
-
Phoenix Children s Hospital
Phoenix, Arizona, 85016, United States
-
St Jude Childrens Research Hospital
Memphis, Tennessee, 38105, United States
-
Texas Childrens Hospital
Houston, Texas, 77030, United States
-
University of Minnesota
Minneapolis, Minnesota, 55455, United States
Conditions
Explore the condition pages connected to this study.